Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update.

AJR Am J Roentgenol

Department of Medicine, Division of Endocrinology and Metabolism, McGill University Health Centre, Montreal, QC, Canada.

Published: August 2020

The paradigm of theranostics is based on tailoring therapy for the purpose of optimizing outcomes. This principle is being applied to radioactive iodine therapy. Consequently, thyroid cancer therapy protocols are evolving. The purpose of this article is to promote a modern approach to radioiodine therapy. This article highlights guidelines and position statements, summarizes the prognostication systems of thyroid cancer, and reviews which prescribed activities of I.

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.19.22626DOI Listing

Publication Analysis

Top Keywords

thyroid cancer
12
radioactive iodine
8
iodine therapy
8
therapy
5
therapy differentiated
4
differentiated thyroid
4
cancer 2020
4
2020 update
4
update paradigm
4
paradigm theranostics
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!